The Detroit Tigers announced that Trey Sweeney will miss the rest of the season after undergoing arthroscopic surgery on his right shoulder, the club said, bringing a lingering spring training injury to a definitive, roster-changing end.
Manager A.J. Hinch said the team tried conservative measures before opting for surgery: "He's on the mend, but after trying conservatively to get through this shoulder issue, surgery ended up being the only option," Hinch said, confirming the procedure and the season-ending status for the 26-year-old.
Sweeney had been sidelined since spring training with a shoulder strain. The timing leaves Detroit without the infielder it acquired in July 2024, when the Tigers traded for Sweeney and minor league catcher Thayron Liranzo in exchange for starter Jack Flaherty; Flaherty returned to the Tigers as a free agent ahead of the 2025 season.
The numbers underline why the loss matters. Sweeney played 36 games in 2024, posting a.642 OPS and drawing notice for above-average defense that earned him a spot in Detroit's playoff lineup; he started all seven of the Tigers' 2024 postseason games. But his bat did not carry into 2025: his batting average fell to.196 across 326 plate appearances, a sharp decline from the promise he showed the previous year.
The arc — a bright defensive showing and postseason starts in 2024, followed by a steep offensive drop in 2025 and now surgery — frames the practical impact. Detroit is losing a rostered infielder who had already been unavailable through much of the season, and the club offered no public recovery timetable beyond the announcement that he will not return this year.
The report that surgery was necessary after conservative treatment is the crucial wrinkle. The Tigers' description of events makes clear that Sweeney attempted to play through the issue before electing repair, which helps explain the gap between his 2024 contributions and 2025 production but leaves the club and fans with two open questions: how long will he need to recover, and whether he can reestablish the defensive value and plate results that justified Detroit trading for him last summer.
For the immediate present, the roster consequence is concrete: the Tigers will proceed without Sweeney for the remainder of the campaign, shifting infield depth decisions onto the front office and coaching staff already managing short-term absences. What remains unresolved is the timeline for his return and the extent to which the surgery will restore the swing and arm strength needed to return him to the kind of below-the-surface value — reliable defense and positional versatility — that made him attractive in the July 2024 trade.
The single most consequential unanswered fact is recovery time. The club's announcement ends any doubt about his 2025 availability but leaves Detroit and Sweeney confronting a rehabilitation window that will determine whether the 26-year-old can convert a brief 2024 breakout into a longer-term role in the Tigers' infield plans.
